Concordance between clinical trial data use request proposals and corresponding publications: A cross-sectional study

一致性 临床试验 数据共享 医学 计算机科学 临床终点 医学物理学 替代医学 内科学 病理
作者
Enrique Vázquez,Joseph S. Ross,Cary P. Gross,Karla Childers,S. P. Bamford,Jessica Ritchie,Joanne Waldstreicher,Harlan M. Krumholz,Joshua D. Wallach
出处
期刊:Clinical Trials [SAGE]
标识
DOI:10.1177/17407745241304355
摘要

Background/Aims The reuse of clinical trial data available through data-sharing platforms has grown over the past decade. Several prominent clinical data-sharing platforms require researchers to submit formal research proposals before granting data access, providing an opportunity to evaluate how published analyses compare with initially proposed aims. We evaluated the concordance between the included trials, study objectives, endpoints, and statistical methods specified in researchers’ clinical trial data use request proposals to four clinical data-sharing platforms and their corresponding publications. Methods We identified all unique data request proposals with at least one corresponding peer-reviewed publication as of 31 March 2023 on four prominent clinical trial data sharing request platforms (Vivli, ClinicalStudyDataRequest.com, the Yale Open Data Access Project, and Supporting Open Access to Researchers–Bristol Myers Squibb). When data requests had multiple publications, we treated each publication–request pair as a unit. For each pair, the trials requested and analyzed were classified as fully concordant, discordant, or unclear, whereas the study objectives, primary and secondary endpoints, and statistical methods were classified as fully concordant, partially concordant, discordant, or unclear. For Vivli, ClinicalStudyDataRequest.com, and Supporting Open Access to Researchers–Bristol Myers Squibb, endpoints of publication–request pairs were not compared because the data request proposals on these platforms do not consistently report this information. Results Of 117 Vivli publication–request pairs, 76 (65.0%) were fully concordant for the trials requested and analyzed, 61 (52.1%) for study objectives, and 57 (48.7%) for statistical methods; 35 (29.9%) pairs were fully concordant across the 3 characteristics reported by all platforms. Of 106 ClinicalStudyDataRequest.com publication–request pairs, 66 (62.3%) were fully concordant for the trials requested and analyzed, 41 (38.7%) for study objectives, and 35 (33.0%) for statistical methods; 20 (18.9%) pairs were fully concordant across the 3 characteristics. Of 65 Yale Open Data Access Project publication–request pairs, 35 (53.8%) were fully concordant for the trials requested and analyzed, 44 (67.7%) for primary study objectives, and 25 (38.5%) for statistical methods; 15 (23.1%) pairs were fully concordant across the 3 characteristics. In addition, 26 (40.0%) and 2 (3.1%) Yale Open Data Access Project publication–request pairs were concordant for primary and secondary endpoints, respectively, such that only one (1.5%) Yale Open Data Access Project publication–request pair was fully concordant across all five characteristics reported. Of three Supporting Open Access to Researchers–Bristol Myers Squibb publication–request pairs, one (33.3%) was fully concordant for the trials requested and analyzed, two (66.6%) for primary study objectives, and two (66.6%) for statistical methods; one (33.3%) pair was fully concordant across all three characteristics reported by all platforms. Conclusion Across four clinical data sharing platforms, data request proposals were often discordant with their corresponding publications, with only 25% concordant across all three key proposal characteristics reported by each platform. Opportunities exist for investigators to describe any data-sharing request proposal deviations in their publications and for platforms to enhance the reporting of key study characteristic specifications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
沙耶酱完成签到,获得积分10
2秒前
SciGPT应助wangtinglk采纳,获得10
2秒前
土豪的鸿煊完成签到,获得积分10
4秒前
5秒前
受伤访波完成签到,获得积分10
6秒前
wangbq完成签到 ,获得积分10
7秒前
9秒前
CC完成签到,获得积分20
9秒前
595893511完成签到,获得积分10
10秒前
小二郎应助日初采纳,获得10
11秒前
柚子发布了新的文献求助10
11秒前
13秒前
14秒前
15秒前
退而求其次完成签到,获得积分10
16秒前
寻风完成签到,获得积分10
17秒前
qly完成签到,获得积分20
17秒前
超级冥幽发布了新的文献求助10
20秒前
kaikai发布了新的文献求助10
20秒前
飘逸的智宸完成签到,获得积分20
21秒前
Elliba完成签到 ,获得积分10
21秒前
过分动真完成签到 ,获得积分10
22秒前
23秒前
deer完成签到,获得积分10
23秒前
yaya关注了科研通微信公众号
23秒前
不喝咖啡会死完成签到 ,获得积分10
24秒前
zxj完成签到,获得积分10
24秒前
顾矜应助mysoul123采纳,获得10
27秒前
Yxy完成签到,获得积分10
27秒前
kaikai完成签到,获得积分20
28秒前
31秒前
二维世界的鱼完成签到,获得积分10
31秒前
肉肉的小屋完成签到,获得积分10
35秒前
蓝泡泡完成签到 ,获得积分10
35秒前
35秒前
Rookie发布了新的文献求助10
35秒前
35秒前
36秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Impiego dell’associazione acetazolamide/pentossifillina nel trattamento dell’ipoacusia improvvisa idiopatica in pazienti affetti da glaucoma cronico 700
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
Geochemistry, 2nd Edition 地球化学经典教科书第二版,不要epub版本 431
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3292168
求助须知:如何正确求助?哪些是违规求助? 2928539
关于积分的说明 8437367
捐赠科研通 2600578
什么是DOI,文献DOI怎么找? 1419116
科研通“疑难数据库(出版商)”最低求助积分说明 660243
邀请新用户注册赠送积分活动 642886